Massivemarkets

Nasdaq: BBTX · Listed Oct 30, 2026

Bambusa Therapeutics IPO

$15.90

▼ -2.75%today · -0.62% since the $16.00 IPO price

15-minute delayed · as of 7:30:02 PM EST on Nov 18, 2026

Bambusa Therapeutics (BBTX) priced its IPO at $16.00 a share and has traded on Nasdaq since Oct 30, 2026.

Last session · Nov 18, 2026

VWAP 16.24open 16.45fell below the open · 9:40$15.96volume · rising bars above the line, falling bars below26.32K9:304:00
Market cap
$809.98M
from the ticker reference
Volume
190.48K
shares, regular session
VWAP
$16.24
the last price is -2.07% from the volume-weighted average
Day range
15.91–16.52
low to high

The trading numbers are from the last session, Nov 18, 2026.

The debut race

BBTX against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%BBTX -0.25%

The IPO scoreboard

BBTX against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

BBTX against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Bambusa Therapeutics '26$168.89M-7.00%-6.31%-1.69%Not yet
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Bambusa Therapeutics IPO offers 10.56M shares to raise $168.89M, before any underwriters' option.

$13$15$16$17$19
Expected price range
$15 to $17
IPO price
$16.00
Shares offered
10.56M
Money raised
$168.89M
Listing date
Oct 30, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Bambusa Therapeutics$168.89M

Where BBTX ranks

Bambusa Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • BBTX$809.98M

What comes after the IPO

Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.

  1. Oct 30, 2026

    First trade

    Prices, bars, and snapshots

  2. Nov 4, 2026 · est.

    Options list

    Option chain and open interest

  3. Nov 19, 2026 · est.

    First short interest

    Short interest and daily short volume

  4. Nov 24, 2026 · est.

    Quiet period ends

    Analyst ratings and price targets

  5. Feb 14, 2027

    First 13F deadline

    Which funds hold the stock

  6. Date not set

    First earnings

    Income statement and ratios

  7. Apr 27, 2027 · est.

    Lock-up expires

    Insider sales on Form 4

Filings and the company

What Bambusa Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Bambusa Therapeutics discloses to the SEC on Form 8-K.

  • Charter amendmentNov 3, 2026

    On November 2, 2026, Bambusa Therapeutics, Inc. (the "Company") filed an amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware in connection with the completion of the Company's initial public offering (the "IPO").

About Bambusa Therapeutics

Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

Ticker
BBTX
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Listed
Oct 30, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Bambusa Therapeutics IPO price?

$16.00 a share.

When did Bambusa Therapeutics go public?

Bambusa Therapeutics listed on Nasdaq on Oct 30, 2026 under the ticker BBTX.

How much did the Bambusa Therapeutics IPO raise?

$168.89M, before any underwriters' option.

How did Bambusa Therapeutics open on its first day?

BBTX first traded at $14.88, -7.00% from the IPO price of $16.00.

How did BBTX close on its first day?

Its last regular-session trade was $14.99, -6.31% from the IPO price of $16.00.

What was the BBTX first-day trading range?

$13.60 to $15.66 in the regular session.

How many BBTX shares traded on the first day?

2.03M shares in the regular session.

How many shares did Bambusa Therapeutics sell in its IPO?

10.56M shares.

What exchange is BBTX listed on?

Bambusa Therapeutics lists on Nasdaq under the ticker BBTX.

Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

Build with Massive

Get the BBTX data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/BBTX/range/5/minute
Market cap/v3/reference/tickers/BBTX
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.